MYND Life Sciences Financial Overview
MYND Life Sciences's market cap is currently $2.45M. The company's EPS TTM is $; its P/E ratio is -2.39; MYND Life Sciences is scheduled to report earnings on June 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.